Scinopharm

Company specializing in R&D and manufacturing of cGMP APIs and peptides

placeTainan, Tainan City, Taiwan calendar_todayFounded 1997 groups1,010 employees language scinopharm.com

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace dormant. Cited 4 times.

Social engagement

Social engagement: 1.7K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%

Recent activity

22 Apr 2026
Event
Scaling Peptide Production with MCSGP: A GMP Case Study on Productivity Optimization
21 Jan 2026
Milestone
regulatory
5 Jan 2026
Milestone
regulatory
Coming soon